Salubris: Ennalapril (Enalapril Tablets) new indication approved for drug registration certificate
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Salubris (002294.SZ) announced that the company has received the drug registration certificate for Enarodustat (Enaro®) approved by the National Medical Products Administration, which is approved for the treatment of anemia in patients with chronic kidney disease (CKD) undergoing dialysis (including hemodialysis and peritoneal dialysis)